European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading; Index Set to End Week 3.7% Lower

European equities traded in the US as American depositary receipts were trending lower late Friday morning, declining 0.7% to 1,420.41 on the S&P Europe Select ADR Index, which is on pace to end the week down 3.7%.

From continental Europe, the gainers were led by biopharmaceutical company Genfit (GNFT) and medical device maker EDAP TMS (EDAP), which rose 5% and 3.8% respectively. They were followed by electronics company Koninklijke Philips (PHG) and pharmaceutical company Novo Nordisk (NVO), which increased 1% and 0.9% respectively.

The decliners from continental Europe were led by biopharmaceutical company DBV Technologies (DBVT) and semiconductor company Sequans Communications (SQNS), which dropped 7.1% and 4.5% respectively. They were followed by biopharmaceutical companies Cellectis (CLLS) and Grifols (GRFS), which lost 3.4% and 3.3% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company NuCana (NCNA) and pharmaceutical company GSK (GSK), which advanced 7.9% and 1.2% respectively. They were followed by medical device maker Smith & Nephew (SNN) and tobacco company British American Tobacco (BTI), which were up 1% and 0.6% respectively.

The decliners from the UK and Ireland were led by biotech firm Autolus Therapeutics (AUTL) and biopharmaceutical company Mereo BioPharma Group (MREO), which fell 5.4% and 2.9% respectively. They were followed by biopharmaceutical company Adaptimmune Therapeutics (ADAP) and financial services company Barclays (BCS), which were down 2.7% and 2.2% respectively.